AromatherapyNCT06193876
The Effect of Aromatherapy Before Clinical Practice on Stress, Anxiety and Depression in Midwifery Students
A study testing Petitgrain and ylang-ylang essential oil in people with Aromatherapy and Stress, run by Tuba Kızılkaya at 1 site in Turkey (Türkiye).
Trial summary
This study was planned as a randomized controlled study to determine the effects of petitgrain and ylang ylang oil applied before clinical practice on stress, anxiety and depression in midwifery students. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Aromatherapy, Stress, Depression
- What is being tested?
- Petitgrain and ylang-ylang essential oil
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 75 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 2 Oct 2023to 15 Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being a midwifery student
Who cannot join
- Having an asthma or any other respiration disease
- Trouble of smelling
- Allergies to petitgrain or ylang-ylang essential oil
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Osmaniye Korkut Ata University Hospital
Osmaniye
About this study
Official title: The Effect of Petitgrain and Ylang-ylang Oil Applied Before Clinical Practice on Stress, Anxiety and Depression in Midwifery Students.
This study was planned as a randomized controlled study to determine the effects of petitgrain and ylang ylang oil applied before clinical practice on stress, anxiety and depression in midwifery students.
- Conditions
- Aromatherapy, Stress, Depression
- Being tested
- Petitgrain and ylang-ylang essential oil
- Medical subject headings
- Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Petitgrain and ylang-ylang essential oilOther
Petitgrain and ylan-ylang essential oil will be dropped to the handchief and students will smell it 3 times in a day.
| Study group | Role | What they receive |
|---|---|---|
| Petitgrain group | Active comparator | In this group petitgrain oil will be used Receives: Other: Petitgrain and ylang-ylang essential oil |
| Ylang-ylang group | Active comparator | In this group ylang-ylang oil will be used Receives: Other: Petitgrain and ylang-ylang essential oil |
| Placebo group | Placebo comparator | In this group water will be used Receives: Other: Petitgrain and ylang-ylang essential oil |
What is being measured
The primary outcome is the main question the study is designed to answer.
depression level
Measured: 1 day
stress level
Measured: 1 day
anxiety level
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2024
- Study start2 Oct 2023
- Primary completion31 Jan 2024
- Study completion15 Jun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AromatherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tuba Kızılkaya
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Tuba Kızılkaya, Balikesir University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06193876
- Sponsor's protocol ID
- 20072023
- Status last verified
- Jul 2024
- First submitted
- 21 Dec 2023
- Last updated
- 18 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Petitgrain and Ylang-ylang Oil Applied Before Clinical Practice on Stress, Anxiety and Depression in Midwifery Students.
- ClinicalTrials.gov ID
- NCT06193876
- Acronym / sponsor ID
- 20072023
- Conditions
- Aromatherapy, Stress, Depression
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 75 participants (actual)
- Lead sponsor
- Tuba KızılkayaUniversity, hospital or other
- Study start
- 2 Oct 2023 (actual)
- Primary completion
- 31 Jan 2024 (actual)
- Study completion
- 15 Jun 2024 (actual)
- First posted
- 5 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was planned as a randomized controlled study to determine the effects of petitgrain and ylang ylang oil applied before clinical practice on stress, anxiety and depression in midwifery students.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Petitgrain group | Active comparator | Other: Petitgrain and ylang-ylang essential oilIn this group petitgrain oil will be used |
| Ylang-ylang group | Active comparator | Other: Petitgrain and ylang-ylang essential oilIn this group ylang-ylang oil will be used |
| Placebo group | Placebo comparator | Other: Petitgrain and ylang-ylang essential oilIn this group water will be used |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Being a midwifery student
Key exclusion criteria (3 listed)
- Having an asthma or any other respiration disease
- Trouble of smelling
- Allergies to petitgrain or ylang-ylang essential oil
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Petitgrain and ylang-ylang essential oilPetitgrain and ylan-ylang essential oil will be dropped to the handchief and students will smell it 3 times in a day. | Other | Petitgrain group, Placebo group, Ylang-ylang group |
Primary outcome
depression level
Time frame: 1 day
stress level
Time frame: 1 day
anxiety level
Time frame: 1 day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jul 2024.
Related trials for Aromatherapy
Recruiting
The Effects of Wintergreen Essential Oil Inhalation on Alleviating Dyspnea Among Patients With Pneumonia
Pneumonia, Dyspnea
Recruiting
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Recruiting
Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy
Cancer
Active, not recruiting
Deep Breathing Relaxation and Lemongrass Aromatherapy on Pain
Chronic Kidney Disease; End-Stage Renal Disease; Hemodialysis; Pain; Anxiety
Enrolling by invitation
The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients
Fibromyalgia, Aromatherapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Petitgrain and ylang-ylang essential oil in people with Aromatherapy and Stress, run by Tuba Kızılkaya at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
depression level (time frame: 1 day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2024.